Treatment of heart failure by calcium cycling gene therapy.
about
Molecular targets in heart failure gene therapy: current controversies and translational perspectivesHigh-throughput FRET assay yields allosteric SERCA activatorsSarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.Molecular targets of current and prospective heart failure therapies.Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models.
P2860
Treatment of heart failure by calcium cycling gene therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment of heart failure by calcium cycling gene therapy.
@en
type
label
Treatment of heart failure by calcium cycling gene therapy.
@en
prefLabel
Treatment of heart failure by calcium cycling gene therapy.
@en
P2093
P2860
P356
P1433
P1476
Treatment of heart failure by calcium cycling gene therapy.
@en
P2093
Anne-Marie Lompre
Roger J Hajjar
Yoshiaki Kawase
P2860
P304
P356
10.2217/14796678.3.4.413
P577
2007-07-01T00:00:00Z